Top

Published in:

01-05-2005 | Cardiac

MRI in guiding and assessing intramyocardial therapy

Authors: M. Saeed, D. Saloner, O. Weber, A. Martin, C. Henk, C. Higgins

Published in: European Radiology | Issue 5/2005

Abstract

Cardiovascular intervention, using MRI guidance, is challenging for clinical applications. Real-time imaging sequences with high spatial resolution are needed for monitoring intramyocardial delivery of drug, gene, or stem cell therapies. New generation MR scanners make local intramyocardial and vascular wall therapies feasible. Contrast-enhanced MRI is used for assessing myocardial ischemia, infarction, and scar tissue. Active (microcoils) and passive (T1 and T2* mechanisms) tracking methods have been used for visualization of endovascular catheters. Safety issues related to potential heating of endovascular devices is still a major obstacle for MRI-guided interventions. Fabrication of MRI-compatible interventional devices is limited. Noninvasive imaging strategies will be critical in defining spatial and temporal characteristics of angiogenesis and myocardial repair as well as in assessing the efficacy of new therapies in ischemic heart disease. MRI contrast media improve the capability of MRI by delineating the target and vascular tree. Labeling stem cells enables MRI to trace distribution, differentiation, and survival in myocardium and vascular wall. In the long term, MRI in guiding and assessing intramyocardial therapy may circumvent the limitations of peripherally administered cell therapy, X-ray angiography, and nuclear imaging. MRI represents a highly attractive discipline whose systematic development will foster the implementation of new cardiac and vascular therapies.

American Heart Association (2001) Heart and stroke statistical update. America Heart Association, Dallas, TX

Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, Angell WW, Petracek MR, Shaar CJ, O’Neill WW (1999) Comparison of transmural revascularization with medical therapy in patients with refractory angina. N Engl J Med 341:1029–1036CrossRef

Zhou YF, Stabile E, Walker J, Shou M, Baffour R, Yu Z, Rott D, Yancopoulos GD, Rudge JS, Epstein SE (2004) Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. J Am Coll Cardiol 18(44):897–903CrossRef

Hellermann JP, Jacobsen SJ, Gersh BJ, Rodeheffer RJ, Reeder GS, Roger VL (2002) Heart failure after myocardial infarction: a review. Am J Med 113:324–330CrossRef

Rezaee M, Yeung AC, Altman P, Lubbe D, Takeshi S, Schwartz RS, Stertzer S, Altman JD (2001) Evaluation of the percutaneous intramyocardial injection for local myocardial treatment. Catheter Cardiovasc Interv 53:271–276CrossRef

Sanborn TA, Hackett NR, Lee LY, El-Sawy T, Blanco I, Tarazona N, Deutsch E, Crystal R, Rosengart TK (2001) Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv 52:260–2666

Esakof DD, Maysky M, Losordo DW, Vale PR, Lathi K, Pastore JO, Symes JF, Isner JM (1999) Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris. Hum Gene Ther 10:2307–2314CrossRef

Seiler C, Fleisch M, de Marchi SF, Billinger M, Wahl A, Eberli FR, Garachemani AR, Meier B (1998) Functional assessment of collateral in the human coronary circulation. Semin Interv Cardiol 3:13–19

Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, Epstein SE (2003) Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41:1721–1724CrossRef

10.

Wolf T, Gepstein L, Drorr U et al (2001) Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol 37:1591–1597CrossRef

11.

Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP (2003) Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361(9351):47–49CrossRef

12.

Perin EC, Silva GV, Sarmento-Leite R, Sousa AL, Howell M, Muthupillai R, Lambert B, Vaughn WK, Flamm SD (2002) Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 106:957–961

13.

Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, Esakof DD, Maysky M, Symes JF, Isner JM (2001) Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103:2138–2143

14.

Thomas JW, Kuo MD, Chawla M, Waugh JM, Yuksel E, Wright KC, Gerrity PM, Shenaq SM, Whigham CJ, Fisher RG (1998) Vascular gene therapy. Radiographics 18:1373–1394

15.

Kandarpa K (2000) Catheter-based techniques for endovascular local drug delivery. J Vasc Interv Radiol Suppl 11:419–423

16.

Yang X, Atalar E, Li D, Serfaty JM, Wang D, Kumar A, Cheng L (2001) Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 104:1588–1590

17.

Fahrig R, Butts K, Wen Z, Saunders R, Kee ST, Sze DY, Daniel BL, Laerum F, Pelc NJ (2001) A truly hybrid interventional MR/X-ray system: feasibility demonstration. J Magn Reson Imaging 13:294–300CrossRefPubMed

18.

Vogl TJ, Balzer JO, Mack MG, Bett G, Oppelt A (2002) Hybrid MR interventional imaging system; combined MR and angiography suites with single interactive table: feasibility study in vascular liver tumor procedures. Eur Radiol 12:1394–1400CrossRefPubMed

19.

Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290–2293

20.

Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147CrossRefPubMed

21.

Dick AJ, Guttman MA, Raman VK, Peters DC, Pessanha BS, Hill JM, Smith S, Scott G, McVeigh ER, Lederman RJ (2003) Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 108:2899–2904

22.

Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ (2003) Serial cardiac magnetic resonance imaging (MRI) of injected mesenchymal stem cells. Circulation 108:1009–1014

23.

Kuehne T, Saeed M, Higgins CB, Gleason K, Krombach GA, Weber OM, Martin AJ, Turner D, Teitel D, Moore P (2003) MRI guided deployment and postinterventional assessment of endovascular stents in the pulmonary position in swine. Radiology 226:475–481

24.

Saeed M, Lee R, Martin A, Weber O, Krombach GA, Schalla S, Lee M, Saloner D, Higgins CB (2004) Transendocardial delivery of extracellular tracers using a combination of X-ray and MRI fluoroscopy (XMR)-guidance: feasibility study in dogs. Radiology 231:689–696

25.

Schalla S, Saeed M, Higgins CB, Martin A, Weber O, Moore P (2003) Magnetic resonance imaging-guided cardiac catheterization in swine model of atrial septal defect. Circulation 108:1865–1870

26.

Razavi R, Hill DL, Keevil SF, Miquel ME, Muthurangu V, Hegde S, Rhode K, Barnett M, van Vaals J, Hawkes DJ, Baker E (2003) Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 362:1877–1882CrossRef

27.

Engellau L, Olsrud J, Brockstedt S, Albrechtsson U, Norgren L, Stahlberg F, Larsson EM (2000) MR evaluation ex vivo and in vivo of a covered stent-graft for abdominal aortic aneurysms: ferromagnetism, heating, artifacts and velocity mapping. J Magn Reson Imaging 12:112–121CrossRef

28.

Lewin JS, Duerk JL, Jain VR, Petersilge CA, Chao CP, Haaga JR (1996) Needle localization in MR-guided biopsy and aspiration: effect of field strength, sequence design and magnetic field orientation. Am J Roentgenol 166:1337–1345

29.

Kuehne T, Saeed M, Reddy G, Akbari H, Gleason K, Turner D, Teitel D, Moore P, Higgins CB (2001) Sequential magnetic resonance monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing swine. Circulation 104:2363–2368

30.

Buecker A, Spuentrup E, Ruebben A, Mahnken A, Nguyen TH, Kinzel S, Gunther RW (2004) New metallic MR stents for artifact-free coronary MR angiography: feasibility study in a swine model. Invest Radiol 39:250–253CrossRef

31.

Leung DA, Debatin JF, Wildermuth S, McKinnon GC, Holtz D, Dumoulin CL, Darrow RD, Hofmann E, von Schulthess GK (1995) Intravascular MR tracking catheter: preliminary experimental evaluation. Am J Roentgenol 164:1265–1270

32.

Dumoulin CL, Souza SP, Darrow RD (1993) Real-time position monitoring of invasive devices using magnetic resonance. Magn Reson Med 29:411–415

33.

Glowinski A, Kursch J, Adam G, Bucker A, Noll TG, Gunther RW (1998) Device visualization for interventional MRI using local magnetic fields: basic theory and its application to catheter visualization. IEEE Trans Med Imag 17:786–793CrossRef

34.

Bakker CJ, Hoogeveen RM, Weber J, van Vaals JJ, Viergever MA, Mali WP (1996) Visualization of dedicated catheters using fast scanning techniques with potential for MR-guided vascular interventions. Magn Reson Med 36:816–820

35.

Bakker CJ, Hoogeveen RM, Hurtak WF, van Vaals JJ, Viergever MA, Mali WP (1997) MR-guided endovascular interventions: susceptibility-based catheter and near real-time imaging technique. Radiology 202:273–276

36.

Wacker FK, Reither K, Branding G, Wendt M, Wolf KJ (1999) Magnetic resonance-guided vascular catheterization: feasibility using a passive tracking technique at 0.2 Tesla in a pig model. J Magn Reson Imaging 10:841–844

37.

Ladd ME, Erhart P, Debatin JF, Hofmann E, Boesiger P, von Schulthess GK, McKinnon GC (1997) Guidewire antennas for MR fluoroscopy. Magn Reson Med 37:891–897

38.

Ocali O, Atalar E (1997) Intravascular magnetic resonance imaging using a loopless catheter antenna. Magn Reson Med 37:112–118

39.

Unal O, Korosec FR, Frayne R, Strother CM, Mistretta CA (1998) A rapid 2D time-resolved variable-rate k-space sampling MR technique for passive catheter tracking during endovascular procedures. Magn Reson Med 40:356–362

40.

Nanz D, Weishaupt D, Quick HH, Debatin JF (2000) TE-switched double-contrast enhanced visualization of vascular system and instruments for MR-guided interventions. Magn Reson Med 43:645–648

41.

Ladd ME, Quick HH (2000) Reduction of resonant RF heating in intravascular catheters using coaxial chockes. Magn Reson Med 43:615–619

42.

Yeung CJ, Atalar E (2000) RF transmit power limit for the barewire loopless catheter antenna. J Magn Reson Imaging 12:86–91CrossRef

43.

Saeed M, Wendland MF, Watzinger N, Akbari H, Higgins CB (2000) MR contrast media for myocardial viability, microvascular integrity and perfusion. Eur J Radiol 34:179–195CrossRef

44.

Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002PubMed

45.

Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985–1991CrossRefPubMed

46.

Wilke NM, Zenovich AG, Jerosch-Herold M, Henry TD (2001) Cardiac magnetic resonance imaging for the assessment of myocardial angiogenesis. Curr Interv Cardiol Rep 3:205–212

47.

Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE (2004) Analysis of myocardial perfusion MRI. J Magn Reson Imaging 6:758–770CrossRef

48.

Saeed M, Higgins CB, Geschwind JF, Wendland MF (2000) T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echoplanar MR imaging. Eur Radiol 10:310–318CrossRef

49.

Saeed M, van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, Brasch RC (1998) Histologic confirmation of microvascular permeability of macromolecular MR contras medium in reperfused myocardium infarction. J Magn Reson Imaging 8:561–567

50.

Gaillard S, Kubiak C, Stolz C, Bonnemain B, Chassard D (2002) Safety and pharmacokinetics of p792, a new blood-pool agent: results of clinical testing in nonpatient volunteers. Invest Radiol 37:161–166CrossRef

51.

Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schaechinger V, Dimmeler S, Zeiher AM (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Circulation 108:2212–2218CrossRefPubMed

52.

Pearlman JD, Laham RJ, Simons M (2000) Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation-preliminary study in pigs. Radiology 214:801–809

53.

Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, Simons M, Hung D (2000) Intramyocardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 292:795–802

54.

Pearlman DJ, Laham RJ, Post M, Leiner T, Simons M (2002) Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis. Curr Pharm Des 8:1467–1496

55.

Marchal G, Ni Y, Herijgers P, Flameng W, Petre C, Bosmans H, Yu J, Ebert W, Hilger CS, Pfefferer D, Semmler W, Baert AL (1996) Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 6:2–8CrossRef

56.

Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M (2002) The potential of contrast enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging 16:633–640CrossRef

57.

Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction using necrosis specific and extracellular nonspecific contrast media. Circulation 103:871–876

58.

Pislaru SV, Ni Y, Pislaru C, Bosmans H, Miao Y, Bogaert J, Dymarkowski S, Semmler W, Marchal G, Van de Werf FJ (1999) Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 99:690–696

59.

Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ (2003) Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation 108:605–609CrossRefPubMed

60.

Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H (2003) Tissue-specific MR contrast agents. Eur J Radiol 46:33–44CrossRef

61.

Lederman RJ, Guttman MA, Peters DC, Thompson RB, Sorger JM, Dick AJ, Raman VK, McVeigh ER (2002) Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation 105:1282–1284

62.

Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF (1997) Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 64:993–998CrossRef

63.

Guttman MA, McVeigh ER (2001) Techniques for fast stereoscopic MRI. Magn Reson Med 46:317–323

64.

Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK (2000) Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102:E73–E86

65.

Thompson WD, Li WW, Maragoudakis M (2000) The clinical manipulation of angiogenesis: pathology, side-effects, surprises and opportunities with novel human therapies. J Pathol 190:330–337CrossRef

66.

Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, control clinical trail. Circulation 105:788–793

67.

Zerhouni EA, Parish DM, Rogers WJ, Yang A, Shapiro EP (1988) Human heart: tagging with MR imaging—a method for noninvasive assessment of myocardial motion. Radiology 169:59–63

68.

Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E (1999) Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99:763–770PubMed

69.

Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, Link KM (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702PubMed

70.

Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2:271–278

71.

Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101:1379–1386

72.

Nagel E, Stuber M, Lakatos M, Scheidegger MB, Boesiger P, Hess OM (2000) Cardiac rotation and relaxation after anterolateral myocardial infarction. Coron Artery Dis 11:261–267CrossRef

73.

Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factor: first clinical results of a new treatment of coronary heart disease. Circulation 97:645–650

74.

Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: phase 1 assessment of direct intramyocardial administration of an adenovirus vector expression VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468–474

75.

Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M (1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase 1 randomized, double-blind, placebo-controlled trial. Circulation 100:1865–1871

76.

Stegmann TJ, Hoppert T, Schneider A, Gemeinhardt S, Kocher M, Ibing R, Strupp G (2000) Induction of myocardial neo-angiogenesis by human growth factors: a new therapeutic option in coronary heart disease. Herz 25:589–599

77.

Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM (1998) Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800–2804

78.

Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, Galt JR, Pike M, Yoshizawa C, Simons M (2000) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities inpatients with severe symptomatic chronic coronary artery disease. Circulation 102:1605–1610

79.

Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Bonow RO (2000) Intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 101:118–121

80.

Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE (2002) Phase 1/2 placebo-controlled, double-blinded, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105:2012–2018

81.

Vale PR, Losordo DW, Milliken CE, Esakof DD, Isner JM (1999) Images in cardiovascular medicine: percutaneous myocardial gene transfer of phVEGF-2. Circulation 100:2462–2463

82.

Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER, VIVA Investigators (2003) The VIVA trial: vascular endothelial growth factor in ischemia or vascular angiogenesis. Circulation 107:1359–1365

83.

Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium—feasibility, cell migration and body distribution. Circulation 108:863–868

84.

Wang JS, Shum-Tim D, Chedrawy E, Chiu RC (2001) The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 122:699–705CrossRef

85.

Krombach GA, Baireuther R, Higgins CB, Saeed M (2004) Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume. Eur Radiol 14:334–340CrossRef

86.

Lazarous DF, Shou M, Stiber JA, Dadhania DM, Thirumurti V, Hodge E, Unger EF (1997) Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 36:78–85CrossRef

87.

Buschmann I, Schaper W (1999) Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol Sci 14:121–125

88.

Helisch A, Schaper W (2003) Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83–97CrossRefPubMed

89.

Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner JM (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830–836CrossRef

90.

Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P (2003) Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 3:86–88

91.

Fujii H, Tomita S, Nakatani T, Fukuhara S, Hanatani A, Ohtsu Y, Ishida M, Yutani C, Miyatake K, Kitamura S (2004) A novel application of myocardial contrast echocardiography to evaluate angiogenesis by autologous bone marrow cell transplantation in chronic ischemic pig model. J Am Coll Cardiol 7:1299–1305CrossRef

92.

Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913–1918

93.

Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, Long TI, Laird PW, Kloner RA (2002) Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105:1720–1726

94.

Scorsin M, Marotte F, Sabri A, Le Dref O, Demirag M, Samuel JL, Rappaport L, Menasche P (1996) Can grafted cardiomyocytes colonize peri-infarcted myocardial areas? Circulation 94[Suppl II]:337–340

95.

Scorsin M, Hagege AA, Marotte F, Mirochnik N, Copin H, Barnoux M, Sabri A, Samuel JL, Rappaport L, Menasche P (1997) Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 96[Suppl II]:188–193

96.

Schaechinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann W-K, Martin H, Dimmeler S, Zeiher AM (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44:1690–1699CrossRef

97.

Crich SG, Biancone L, Cantaluppi V, Duo D, Esposito G, Russo S, Camussi G, Aime S (2004) Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med 51:938–944CrossRefPubMed

98.

Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, Su H, Edwards S, Hiu S, Harris TD, Madri JA, Zaret BL, Sinusas AJ (2004) Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 113:1684–1691CrossRef

Title: MRI in guiding and assessing intramyocardial therapy
Authors: M. Saeed
D. Saloner
O. Weber
A. Martin
C. Henk
C. Higgins
Publication date: 01-05-2005
Publisher: Springer-Verlag
Published in: European Radiology / Issue 5/2005
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-004-2622-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

MRI in guiding and assessing intramyocardial therapy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2005

A case of bilateral sensory deficits in upper and lower extremities in a woman (2005:5a)

Imaging of the complications of laparoscopic cholecystectomy

Measuring tongue volumes and visualizing the chewing and swallowing process using real-time TrueFISP imaging—initial clinical experience in healthy volunteers and patients with acromegaly

Short tau inversion recovery and proton density-weighted fat suppressed sequences for the evaluation of osteoarthritis of the knee with a 1.0 T dedicated extremity MRI: development of a time-efficient sequence protocol

CT imaging in acute pulmonary embolism: diagnostic strategies

Compression of the extrahepatic bile duct by the portal vein: a diagnostic pitfall of MR cholangiopancreatography